CD4 and idiopathic pulmonary fibrosis: Given that CD28% values have also been shown to associate with outcome measures in other populations with chronic immunologic disorders [20]–[23], [32]–[34], we tested the hypothesis that these quantitative CD4 T-cell phenotype assays might have clinical prognostic value for patients with IPF.